INTERNATIONAL WAREHOUSE π (332 Offers)
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Letrozole Oral aromatase inhibitor
2.5 mg per tablet
Form Oral Tablets
Packaging 50 or 100 Tablets
Estimated Half-Life Approximately 2 Days
Detection Up to several weeks
Primary Mechanism Aromatase Inhibition
Estrogen Suppression Very High
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Tamoxifen Citrate Oral selective estrogen receptor modulator
20 mg per tablet
Form Oral Tablets
Packaging 50 or 100 Tablets
Estimated Half-Life Approximately 5–7 Days
Detection Up to several weeks
Primary Mechanism Mixed ER Agonist / Antagonist
HPTA Support High
Laboratory Tested
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Clenbuterol Hydrochloride Oral beta-2 adrenergic agonist
40 mcg per tablet
Form Oral Tablets
Packaging 100 Tablets
Estimated Half-Life Approximately 36–48 Hours
Detection Up to 4–6 Days (plasma)
Primary Mechanism Beta-2 Adrenergic Agonism
Thermogenic Effect High
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance BPC-157 Lyophilized synthetic pentadecapeptide
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Multidose Vial
Estimated Half-Life Limited human data
Detection Up to several weeks
Primary Mechanism Angiogenesis / VEGF Pathway Upregulation
Tissue Repair / Healing High (preclinical)
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance GHK-Cu (Copper Peptide) Lyophilized copper-binding tripeptide
50 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Short-acting
Detection Up to several weeks
Primary Mechanism Copper-Dependent Collagen & Tissue Remodeling
Tissue Repair / Healing High (preclinical)
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Ipamorelin Lyophilized growth hormone releasing peptide
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 2 Hours
Detection Up to several weeks
Primary Mechanism Ghrelin / GHS-R1a Receptor Agonism
GH / IGF-1 Impact Moderate to High
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance MOTS-c Lyophilized mitochondrial-derived peptide (12S rRNA-c)
10 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Short-acting
Detection Up to several weeks
Primary Mechanism AMPK Activation / Mitochondrial Retrograde Signalling
Metabolic / Endurance Impact High
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Sermorelin Acetate Lyophilized GHRH analogue (GHRH 1-29)
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 10–20 Minutes
Detection Up to several weeks
Primary Mechanism GHRH Receptor Agonism
GH / IGF-1 Impact Moderate
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Thymosin Beta-4 Lyophilized synthetic peptide (full-length, 43 aa)
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Short-acting
Detection Up to several weeks
Primary Mechanism Actin Cytoskeleton Regulation / Cell Migration
Tissue Repair / Healing Moderate
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Tesamorelin Lyophilized GHRH analogue (GHRH 1-44)
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 30–40 Minutes
Detection Up to several weeks
Primary Mechanism GHRH Receptor Agonism
GH / IGF-1 Impact Moderate to High
Coming Soon!
Dragon Pharma, Europe
Product Information
Dragon PharmaCompound Details
Active Formula
3 Actives
Testosterone Acetate
60 mg
Testosterone Enanthate
142 mg
Testosterone Decanoate
198 mg
Form Multi-Ester Injectable Solution
Packaging 10 mL Vial
Estimated Half-Life Varies by Ester (2–15 Days)
Detection Up to 2–3 Months
Liver Toxicity Low
Water Retention High
Coming Soon!
Dragon Pharma, Europe
Product Information
Dragon PharmaCompound Details
Active Formula
3 Actives
Trenbolone Enanthate
100 mg
Drostanolone Enanthate
100 mg
Testosterone Enanthate
200 mg
Form Multi-Ester Injectable Solution
Packaging 10 mL Vial
Estimated Half-Life Approximately 7–10 Days
Detection Up to 4–6 Months
Liver Toxicity Low
Water Retention Moderate
Coming Soon!
Dragon Pharma, Europe
Product Information
Dragon PharmaCompound Details
Active Substance Dihydroboldenone Cypionate Injectable anabolic-androgenic steroid
100 mg per mL
Form Injectable Solution
Packaging 10 mL Vial
Estimated Half-Life Approximately 8–10 Days
Detection Up to 4–6 Months
Liver Toxicity Low
Water Retention Low
Coming Soon!
Product Information
Dragon PharmaCompound Details
Active Substance Trenbolone Acetate Short-ester injectable anabolic-androgenic steroid
75 mg per mL
Form Injectable Solution
Packaging 10 mL Vial
Estimated Half-Life Approximately 1–2 Days
Detection Up to 4–6 Months
Liver Toxicity Low
Water Retention Low
Coming Soon!
Dragon Pharma, Europe
Product Information
Dragon PharmaCompound Details
Active Substance Trestolone Enanthate Long-ester injectable anabolic-androgenic steroid
100 mg per mL
Form Injectable Solution
Packaging 10 mL Vial
Estimated Half-Life Approximately 7–10 Days
Detection Limited data · Up to several months
Liver Toxicity Low
Water Retention High
Dragon Pharma, Europe
Product Information
Dragon PharmaCompound Details
Active Substance Fluoxymesterone Oral anabolic-androgenic steroid
25 mg per tablet
Form Oral Tablets
Packaging 100 Tablets
Estimated Half-Life Approximately 9–10 Hours
Detection Up to 1–2 Months
Liver Toxicity High
Water Retention Low